|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-5-16
|
|
pubmed:abstractText |
Selenium (Se) in the form of selenocysteine is an essential component of the family of the detoxifying enzymes glutathione peroxidase (Gpx) and of the iodothyronine selenodeiodinases that catalyze the extrathyroidal production of tri-iodothyronine (T(3)). Thus, Se deficiency may seriously influence the generation of free radicals, the conversion of thyroxine (T(4)) to T(3) and a thyroidal autoimmune process. The aim of this study was to investigate whether serum Se levels may influence the outcome of Graves' disease (GD).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1573-4064
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
3
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
281-4
|
|
pubmed:dateRevised |
2008-2-26
|
|
pubmed:meshHeading |
pubmed-meshheading:17504200-Adult,
pubmed-meshheading:17504200-Aged,
pubmed-meshheading:17504200-Autoantibodies,
pubmed-meshheading:17504200-Female,
pubmed-meshheading:17504200-Graves Disease,
pubmed-meshheading:17504200-Humans,
pubmed-meshheading:17504200-Male,
pubmed-meshheading:17504200-Middle Aged,
pubmed-meshheading:17504200-Receptors, Thyrotropin,
pubmed-meshheading:17504200-Recurrence,
pubmed-meshheading:17504200-Remission Induction,
pubmed-meshheading:17504200-Retrospective Studies,
pubmed-meshheading:17504200-Selenium,
pubmed-meshheading:17504200-Selenocysteine,
pubmed-meshheading:17504200-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Serum selenium levels in patients with remission and relapse of graves' disease.
|
|
pubmed:affiliation |
Department of Endocrinology, Diabetes and Rheumatology, University Hospital Duesseldorf, Duesseldorf, Germany.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
